Amgen Inc (AMGN) shareholders
Close on Nov 17, 2026Market cap $247.57BP/E 26.5Yield 2.11%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 40,830,830 | 7.60% | 13G (passive) amendment | Mar 31, 2025 |
| Vanguard Capital Management | 40,510,484 | 7.51% | 13G (passive) | Mar 31, 2026 |
| Capital World Investors | 29,596,119 | 5.50% | 13G (passive) | Mar 31, 2026 |
| Onyx Pharmaceuticals, Inc. Joint filing with Saga Investments Coöperatief U.A (9.00%), Amgen Singapore Manufacturing Pte. Ltd. (9.00%) and 2 more | – | 9.00% | 13G (passive) amendment | Aug 22, 2024 |
| State Street Corporation | – | 5.52% | 13G (passive) amendment | Dec 31, 2023 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of AMGN | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 49,362,016 | 9.13% | $17.87B | +2,261,544 | 0.27% |
| Vanguard Capital Management LLC | 35,250,101 | 6.52% | $12.76B | +235,869 | 0.27% |
| State Street Corp | 30,560,537 | 5.65% | $11.07B | +12,049 | 0.33% |
| Capital World Investors | 29,075,329 | 5.38% | $10.53B | −213,014 | 1.24% |
| Invesco Ltd. | 16,320,446 | 3.02% | $5.91B | +434,940 | 0.47% |
| Geode Capital Management, LLC | 15,696,068 | 2.90% | $5.67B | +265,544 | 0.30% |
| Charles Schwab Investment Management Inc | 15,034,038 | 2.78% | $5.44B | +2,260,652 | 0.72% |
| Vanguard Portfolio Management LLC | 14,853,366 | 2.75% | $5.38B | +232,218 | 0.24% |
| Morgan Stanley | 13,653,692 | 2.53% | $4.94B | −2,182,366 | 0.26% |
| Wells Fargo & Company/Mn | 7,235,462 | 1.34% | $2.62B | +147,452 | 0.42% |
| Primecap Management Co/Ca/ | 6,756,962 | 1.25% | $2.45B | −2,117,167 | 1.45% |
| Capital Research Global Investors | 6,272,625 | 1.16% | $2.27B | −682,720 | 0.32% |
| Northern Trust Corp | 6,200,994 | 1.15% | $2.25B | −16,844 | 0.26% |
| Norges Bank | 5,625,584 | 1.04% | $2.04B | New | 0.20% |
| UBS Asset Management Americas Inc | 5,390,910 | 1.00% | $1.95B | +605,928 | 0.35% |
| Bank Of America Corp /De/ | 5,058,830 | 0.94% | $1.83B | −62,198 | 0.12% |
| Royal Bank of Canada | 4,328,785 | 0.80% | $1.57B | −142,660 | 0.23% |
| Goldman Sachs Group Inc | 4,130,732 | 0.76% | $1.50B | −89,257 | 0.13% |
| Price T Rowe Associates Inc /Md/ | 3,956,992 | 0.73% | $1.43B | +2,089,803 | 0.14% |
| Amundi | 3,890,189 | 0.72% | $1.41B | +512,883 | 0.34% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 3,146 | 447M | 82.7% | 177 / 1271 | 1226 / 122 | 33M | 23M |
| Q1 2026 | 3,145 | 440M | 81.3% | 225 / 1213 | 1250 / 126 | 84M | 39M |
| Q4 2025 | 3,091 | 451M | 83.4% | 418 / 1184 | 1112 / 95 | 45M | 20M |
| Q3 2025 | 2,826 | 427M | 79.1% | 145 / 1131 | 1152 / 133 | 18M | 27M |
| Q2 2025 | 2,857 | 437M | 80.9% | 146 / 1236 | 1094 / 182 | 26M | 17M |
| Q1 2025 | 2,932 | 429M | 79.3% | 250 / 1135 | 1187 / 132 | 35M | 22M |
| Q4 2024 | 2,860 | 419M | 77.5% | 317 / 1079 | 1131 / 236 | 38M | 33M |
| Q3 2024 | 2,829 | 417M | 77.1% | 174 / 1098 | 1140 / 98 | 63M | 15M |
| Q2 2024 | 2,789 | 415M | 76.8% | 208 / 1146 | 1068 / 100 | 22M | 50M |
| Q1 2024 | 2,719 | 445M | 82.3% | 189 / 1128 | 1021 / 149 | 40M | 25M |
| Q4 2023 | 2,717 | 430M | 79.6% | 343 / 981 | 1045 / 89 | 41M | 16M |
| Q3 2023 | 2,504 | 407M | 75.2% | 253 / 981 | 912 / 111 | 20M | 18M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
1,106 funds held AMGN in Q2 2026, 49% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of AMGN | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 17,134,234 | 3.17% | $6.20B | 0.27% | Jun 30, 2026 |
| Vanguard 500 Index Fund | 13,987,160 | 2.59% | $5.07B | 0.30% | Jun 30, 2026 |
| Invesco QQQ Trust, Series 1 | 11,456,486 | 2.12% | $4.15B | 0.85% | Jun 30, 2026 |
| Schwab U.S. Dividend Equity ETF | 9,787,012 | 1.81% | $3.30B | 3.47% | May 31, 2026 |
| Income Fund of America | 7,758,812 | 1.44% | $2.99B | 2.02% | Jul 31, 2026 |
| iShares Core S&P 500 ETF | 7,422,554 | 1.37% | $2.69B | 0.30% | Jun 30, 2026 |
| American Balanced Fund | 7,087,896 | 1.31% | $2.57B | 0.89% | Jun 30, 2026 |
| Fidelity 500 Index Fund | 6,890,954 | 1.27% | $2.32B | 0.28% | May 31, 2026 |
| Washington Mutual Investors Fund | 6,056,889 | 1.12% | $2.33B | 1.07% | Jul 31, 2026 |
| Vanguard Value Index Fund | 5,136,838 | 0.95% | $1.86B | 0.73% | Jun 30, 2026 |
| Vanguard Primecap Fund | 4,349,446 | 0.80% | $1.58B | 1.64% | Jun 30, 2026 |
| State Street(R) Health Care Select Sector SPDR(R) ETF | 3,812,905 | 0.71% | $1.38B | 3.40% | Jun 30, 2026 |
| Growth Fund of America | 3,336,048 | 0.62% | $1.12B | 0.31% | May 31, 2026 |
| Vanguard Dividend Appreciation Index Fund | 3,053,644 | 0.56% | $1.18B | 0.90% | Jul 31, 2026 |
| Vanguard Institutional Index Fund | 2,929,913 | 0.54% | $1.06B | 0.30% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Robert A. Bradway | Chairman, CEO and President, Director | 655,220 | 0.12% | May 11, 2026 |
| Thomas J.W. Dittrich | EVP & CFO | 16,860 | 0.00% | Sep 4, 2026 |
| Rachna Khosla | SVP, Business Development | 7,656 | 0.00% | Aug 13, 2026 |
| Matthew C. Busch | VP, Finance & CAO | 5,080 | 0.00% | Aug 12, 2026 |
| Derek Miller | SVP, Human Resources | 12,462 | 0.00% | Aug 7, 2026 |
| Nancy A. Grygiel | SVP & CCO | 8,447 | 0.00% | Aug 7, 2026 |
| Murdo Gordon | EVP, Global Commercial Ops | 51,222 | 0.01% | May 11, 2026 |
| Esteban Santos | EVP, Operations | 83,757 | 0.02% | May 11, 2026 |
| David M. Reese | EVP & Chief Technology Officer | 42,256 | 0.01% | May 11, 2026 |
| Peter H. Griffith | EVP & CFO | 50,150 | 0.01% | May 11, 2026 |
| James E. Bradner | EVP, Research and Development | 30,016 | 0.01% | May 11, 2026 |
| Jonathan P. Graham | EVP & Gen. Counsel & Sec. | 39,712 | 0.01% | May 11, 2026 |
| Omar Ishrak | Director | 7,682 | 0.00% | Nov 9, 2026 |
| Michael V. Drake | Director | 6,030 | 0.00% | Nov 9, 2026 |
| Charles M. Holley | Director | 14,522 | 0.00% | Nov 9, 2026 |
| David W. Gibbs | Director | 278 | 0.00% | Nov 9, 2026 |
| Mary E. Klotman | Director | 2,211 | 0.00% | May 21, 2026 |
| Robert Eckert | Director | 26,251 | 0.00% | May 21, 2026 |
| Amy E. Miles | Director | 5,640 | 0.00% | May 21, 2026 |
| Tyler Jacks | Director | 18,284 | 0.00% | May 21, 2026 |
| Greg C. Garland | Director | 13,848 | 0.00% | May 21, 2026 |
| Wanda M. Austin | Director | 8,018 | 0.00% | May 21, 2026 |
| Brian Druker | Director | 8,391 | 0.00% | May 21, 2026 |
| Ellen Jamison Kullman | Director | 14,536 | 0.00% | May 21, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Michael V. Drake Director | Nov 6, 2026 | Award | +114.026 | – | – | 6,030 |
| Omar Ishrak Director | Nov 6, 2026 | Award | +152.035 | – | – | 7,682 |
| Charles M. Holley Director | Nov 6, 2026 | Award | +184.614 | – | – | 13,262 |
| David W. Gibbs Director | Nov 6, 2026 | Award | +278 | – | – | 278 |
| Rachna Khosla SVP, Business Development | Aug 13, 2026 | Option exercise | +1,252 | $162.60 | $203.58K | 7,656 |
| Rachna Khosla SVP, Business Development | Aug 13, 2026 | Sale | −1,252 | $416.43 | $521.37K | 6,404 |
| Rachna Khosla SVP, Business Development | Aug 11, 2026 | Sale | −2,000 | $412.57 | $825.14K | 6,404 |
| Matthew C. Busch VP, Finance & CAO | Aug 7, 2026 | Award | +730 | – | – | 5,080 |
| Omar Ishrak Director | Aug 7, 2026 | Award | +85.17 | – | – | 7,486 |
| Michael V. Drake Director | Aug 7, 2026 | Award | +63.88 | – | – | 5,876 |
| Charles M. Holley Director | Aug 7, 2026 | Award | +103.42 | – | – | 12,990 |
| Derek Miller SVP, Human Resources | Aug 6, 2026 | Sale | −1,821 | $402.54 | $733.03K | 12,462 |
| Derek Miller SVP, Human Resources | Aug 6, 2026 | Option exercise | +1,821 | $177.46 | $323.15K | 14,283 |
| Derek Miller SVP, Human Resources | Aug 6, 2026 | Option exercise | +2,069 | $162.60 | $336.42K | 14,531 |
| Derek Miller SVP, Human Resources | Aug 6, 2026 | Sale | −2,069 | $402.54 | $832.86K | 12,462 |
| Nancy A. Grygiel SVP & CCO | Aug 6, 2026 | Option exercise | +1,000 | $177.31 | $177.31K | 8,340 |
| Nancy A. Grygiel SVP & CCO | Aug 6, 2026 | Option exercise | +1,970 | $177.46 | $349.60K | 9,310 |
| Nancy A. Grygiel SVP & CCO | Aug 6, 2026 | Sale | −1,970 | $402.16 | $792.26K | 7,340 |
| Nancy A. Grygiel SVP & CCO | Aug 6, 2026 | Sale | −1,000 | $402.16 | $402.16K | 7,340 |
| Wanda M. Austin Director | May 19, 2026 | Award | +665 | – | – | 8,018 |
| Brian Druker Director | May 19, 2026 | Award | +665 | – | – | 8,391 |
| Tyler Jacks Director | May 19, 2026 | Award | +665 | – | – | 18,284 |
| Michael V. Drake Director | May 19, 2026 | Award | +665 | – | – | 5,774 |
| Amy E. Miles Director | May 19, 2026 | Award | +665 | – | – | 5,640 |
| Greg C. Garland Director | May 19, 2026 | Award | +665 | – | – | 13,848 |
| Omar Ishrak Director | May 19, 2026 | Award | +665 | – | – | 7,359 |
| Mary E. Klotman Director | May 19, 2026 | Award | +665 | – | – | 2,211 |
| Robert Eckert Director | May 19, 2026 | Award | +665 | – | – | 26,251 |
| Charles M. Holley Director | May 19, 2026 | Award | +665 | – | – | 12,799 |
| Ellen Jamison Kullman Director | May 19, 2026 | Award | +665 | – | – | 14,536 |
| Jonathan P. Graham EVP & Gen. Counsel & Sec. | May 7, 2026 | Tax withholding | −499 | $331.11 | $165.22K | 39,712 |
| Murdo Gordon EVP, Global Commercial Ops | May 7, 2026 | Tax withholding | −615 | $331.11 | $203.63K | 51,222 |
| Peter H. Griffith EVP & CFO | May 7, 2026 | Tax withholding | −556 | $331.11 | $184.10K | 50,150 |
| David M. Reese EVP & Chief Technology Officer | May 7, 2026 | Tax withholding | −556 | $331.11 | $184.10K | 42,256 |
| Derek Miller SVP, Human Resources | May 7, 2026 | Tax withholding | −151 | $331.11 | $50.00K | 12,444 |
| Robert A. Bradway Chairman, CEO and President, Director | May 7, 2026 | Tax withholding | −2,079 | $331.11 | $688.38K | 505,160 |
| Rachna Khosla SVP, Business Development | May 7, 2026 | Tax withholding | −93 | $331.11 | $30.79K | 8,394 |
| Matthew C. Busch VP, Finance & CAO | May 7, 2026 | Tax withholding | −41 | $331.11 | $13.58K | 4,344 |
| Nancy A. Grygiel SVP & CCO | May 7, 2026 | Tax withholding | −88 | $331.11 | $29.14K | 7,330 |
| James E. Bradner EVP, Research and Development | May 7, 2026 | Tax withholding | −446 | $331.11 | $147.68K | 30,016 |
| Esteban Santos EVP, Operations | May 7, 2026 | Tax withholding | −522 | $331.11 | $172.84K | 82,847 |
| Matthew C. Busch VP, Finance & CAO | May 6, 2026 | Tax withholding | −50 | $329.59 | $16.48K | 4,385 |
| Rachna Khosla SVP, Business Development | May 6, 2026 | Tax withholding | −79 | $329.59 | $26.04K | 8,487 |
| Jonathan P. Graham EVP & Gen. Counsel & Sec. | May 6, 2026 | Tax withholding | −408 | $329.59 | $134.47K | 40,211 |
| Esteban Santos EVP, Operations | May 6, 2026 | Tax withholding | −427 | $329.59 | $140.73K | 83,369 |
| Murdo Gordon EVP, Global Commercial Ops | May 6, 2026 | Tax withholding | −502 | $329.59 | $165.45K | 51,837 |
| James E. Bradner EVP, Research and Development | May 6, 2026 | Tax withholding | −407 | $329.59 | $134.14K | 30,462 |
| David M. Reese EVP & Chief Technology Officer | May 6, 2026 | Tax withholding | −454 | $329.59 | $149.63K | 42,812 |
| Robert A. Bradway Chairman, CEO and President, Director | May 6, 2026 | Tax withholding | −1,702 | $329.59 | $560.96K | 507,239 |
| Nancy A. Grygiel SVP & CCO | May 6, 2026 | Tax withholding | −76 | $329.59 | $25.05K | 7,418 |
| Derek Miller SVP, Human Resources | May 6, 2026 | Tax withholding | −123 | $329.59 | $40.54K | 12,595 |
| Peter H. Griffith EVP & CFO | May 6, 2026 | Tax withholding | −502 | $329.59 | $165.45K | 50,706 |
| Michael V. Drake Director | May 5, 2026 | Award | +79.64 | – | – | 5,109 |
| Matthew C. Busch VP, Finance & CAO | May 5, 2026 | Award | +455 | – | – | 4,435 |
| Charles M. Holley Director | May 5, 2026 | Award | +128.95 | – | – | 12,134 |
| Rachna Khosla SVP, Business Development | May 5, 2026 | Award | +500 | – | – | 8,566 |
| Jonathan P. Graham EVP & Gen. Counsel & Sec. | May 5, 2026 | Award | +2,609 | – | – | 40,619 |
| Esteban Santos EVP, Operations | May 5, 2026 | Award | +2,730 | – | – | 83,796 |
| Murdo Gordon EVP, Global Commercial Ops | May 5, 2026 | Award | +3,640 | – | – | 52,339 |
| James E. Bradner EVP, Research and Development | May 5, 2026 | Award | +3,337 | – | – | 30,869 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Amgen's stock actually held short. Settlement fails (shares not delivered on time) peaked at 19,185 shares on Aug 21, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Rachna Khosla Officer | Aug 13, 2026 | 1,252 | $516.78K | Aug 13, 2026 | Stock Option Exercise |
| Rachna Khosla Officer | Aug 11, 2026 | 2,000 | $828.42K | Aug 11, 2026 | Stock award |
| Nancy A. Grygiel Officer | Aug 6, 2026 | 2,670 | $1.19M | Aug 6, 2026 | Cashless Stock Option Exercise |
| Nancy A. Grygiel Officer | Aug 6, 2026 | 2,970 | $1.19M | Aug 6, 2026 | Cashless Stock Option Exercise |
| Derek Miller Officer | Aug 6, 2026 | 3,890 | $1.57M | Aug 6, 2026 | Acquired as compensation -- Stock Options |
| Nancy A. Grygiel Officer | May 4, 2026 | 1,237 | $400.45K | May 4, 2026 | Performance Unit |
| Esteban Santos Associate | Feb 27, 2026 | 54,792 | $20.77M | Feb 26, 2026 | Equity Compensation 2016 Stock Option Grant |
| Matthew C. Busch ASSOCIATED TO AFFILIATE | Feb 19, 2026 | 1,000 | $375.00K | Feb 19, 2026 | Stock Award |
| Nancy A. Grygiel Officer | Nov 20, 2025 | 3,139 | $1.06M | Nov 20, 2025 | Cashless Stock Option Exercise |
| Murdo Gordon Officer | Nov 12, 2025 | 6,879 | $2.32M | Nov 12, 2025 | Restricted Stock Award |
| Rachna Khosla Officer | Nov 12, 2025 | 890 | $300.30K | Nov 12, 2025 | Stock Award |
| Nancy A. Grygiel Officer | Aug 20, 2025 | 1,267 | $372.91K | Aug 20, 2025 | RSE/DEU Grants |
| Rachna Khosla Officer | Jun 5, 2025 | 1,500 | $435.00K | Jun 5, 2025 | Stock Award |
| Matthew C. Busch Officer | May 2, 2025 | 1,000 | $281.44K | May 2, 2025 | Compensation |
| David M Reese & Joan I Chuco-Ttee Chu-Reese Family Trustu/A Dtd 01/07/2005 Officer | Feb 21, 2025 | 25,225 | $7.68M | Feb 21, 2025 | Restricted stock vesting under a registered plan |
Congress trades
40 trades in Amgen reported by 18 members of the House
| Member | Type | Traded | Amount | Filed |
|---|---|---|---|---|
| David J. Taylor OH02 | Sold | Nov 3, 2026 | $1K–15K | Nov 12, 2026 |
| David J. Taylor OH02 | Sold | Nov 3, 2026 | $1K–15K | Nov 12, 2026 |
| David J. Taylor OH02 | Bought | Sep 22, 2026 | $1K–15K | Oct 1, 2026 |
| David J. Taylor OH02 | Sold | Aug 26, 2026 | $1K–15K | Sep 5, 2026 |
| David J. Taylor OH02 | Sold | Aug 26, 2026 | $1K–15K | Sep 5, 2026 |
| David J. Taylor OH02 | Bought | Jun 5, 2026 | $1K–15K | Jun 12, 2026 |
| Maria Elvira Salazar FL27 | Sold | Apr 17, 2026 | $15K–50K | May 8, 2026 |
| Maria Elvira Salazar FL27 | Bought | Mar 24, 2026 | $15K–50K | Apr 21, 2026 |
| David J. Taylor OH02 | Sold | Feb 26, 2026 | $1K–15K | Mar 6, 2026 |
| Kurt Schrader OR05 | Bought | Feb 5, 2026 | $1K–15K | Apr 1, 2021 |
| David J. Taylor OH02 | Sold | Jan 29, 2026 | $1K–15K | Feb 2, 2026 |
| David J. Taylor OH02 | Bought | Jan 16, 2026 | $1K–15K | Feb 2, 2026 |
| David J. Taylor OH02 | Sold | Dec 3, 2025 | $1K–15K | Dec 5, 2025 |
| David J. Taylor OH02 | Sold | Dec 3, 2025 | $1K–15K | Dec 5, 2025 |
| Marjorie Taylor Greene GA14 | Bought | Oct 24, 2025 | $1K–15K | Oct 28, 2025 |
| Lisa McClain MI09 · spouse | Sold | Sep 25, 2025 | $1K–15K | Oct 22, 2025 |
| Marjorie Taylor Greene GA14 | Bought | Sep 11, 2025 | $1K–15K | Sep 27, 2025 |
| Lisa McClain MI09 · spouse | Bought | Jun 24, 2025 | $1K–15K | Aug 13, 2025 50 days late |
| Cliff Bentz OR02 · spouse | Bought | Jun 6, 2025 | $1K–15K | Jul 9, 2025 |
| Marjorie Taylor Greene GA14 | Bought | May 14, 2025 | $1K–15K | May 19, 2025 |
| Jefferson Shreve IN06 | Sold | May 12, 2025 | $15K–50K | Jun 22, 2025 |
| Marjorie Taylor Greene GA14 | Bought | May 5, 2025 | $1K–15K | May 6, 2025 |
| Jared Moskowitz FL23 | Bought | Apr 16, 2025 | $1K–15K | May 9, 2025 |
| Jared Moskowitz FL23 · child | Bought | Apr 16, 2025 | $1K–15K | May 9, 2025 |
| Jefferson Shreve IN06 | Bought | Apr 11, 2025 | $15K–50K | May 8, 2025 |
| Rob Bresnahan PA08 | Sold | Apr 8, 2025 | $1K–15K | May 8, 2025 |
| Jefferson Shreve IN06 | Bought | Feb 24, 2025 | $15K–50K | Mar 9, 2025 |
| Daniel Meuser PA09 · spouse | Sold | Feb 11, 2025 | $1K–15K | Aug 20, 2025 190 days late |
| Emily Randall WA06 · spouse | Sold | Jan 6, 2025 | $1K–15K | Feb 11, 2025 |
| Virginia Foxx NC05 | Bought | Dec 6, 2024 | $1K–15K | Jan 6, 2025 |
| Julia Letlow LA05 | Sold | Nov 19, 2024 | $1K–15K | Jan 13, 2026 420 days late |
| Julia Letlow LA05 | Bought | Oct 23, 2024 | $1K–15K | Jan 13, 2026 447 days late |
| Scott Scott Franklin FL18 · spouse | Bought | Aug 7, 2024 | $1K–15K | Jul 3, 2025 330 days late |
| C. Scott Franklin FL18 | Bought | Aug 7, 2024 | $50K–100K | Aug 20, 2024 |
| C. Scott Franklin FL18 | Bought | Aug 2, 2024 | $1K–15K | Aug 20, 2024 |
| Kathy Manning NC06 · spouse | Bought | Jul 2, 2024 | $1K–15K | Aug 16, 2024 |
| Kathy Manning NC06 · spouse | Bought | Jan 23, 2024 | $1K–15K | Feb 6, 2024 |
| Michael C. Burgess TX26 · spouse | Sold | Jan 2, 2024 | $15K–50K | Jan 22, 2024 |
| Greg Stanton AZ04 · spouse | Sold | Oct 24, 2023 | $1K–15K | Nov 9, 2023 |
| Greg Stanton AZ04 · spouse | Bought | Sep 26, 2023 | $1K–15K | Nov 9, 2023 |
See a number that looks wrong?